Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose

Tweet this page
<
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 09 Jan 2018
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 01278505562-40

Overview

Lobbying Costs

350,000€

Financial year: Jan 2016 - Dec 2016

Lobbyists (Full time equivalent)

1.5 Fte (3)

Lobbyists with EP accreditation

2

High-level Commission meetings

4

Lobbying Costs over the years

  • Info

    Plasma Protein Therapeutics Association Europe, international Association without lucrative purpose   (PPTA Europe aisbl)

    EU Transparency Register

    687559214721-11 First registered on 20 Oct 2014

    Goals / Remit

    The mission of the Plasma Protein Therapeutics Association (PPTA) is to promote the availability of and access to safe and effective plasma protein therapeutics for all patients in the world. We will strive to achieve our mission by:

    Fostering the collection of high-quality plasma from healthy donors;

    Establishing standards for the manufacturing of life-saving plasma protein therapies at the highest levels of safety and quality;

    Breaking down artificial barriers on trade and compensated donors that limit patient access to therapy;

    Supporting government reimbursement practices that reflect the unique nature of plasma protein therapies;

    Educating all stakeholders about the value of the therapies; and

    Adhering to the PPTA Code of Ethics.

    Main EU files targeted

    DIRECTIVE 2002/98/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood componentsand amending Directive 2001/83/EC

    DIRECTIVE 2004/23/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells

    EU Commission Evaluation of EU OMP Regulation and Paediatrics Regulation

    Address

    Head Office
    Boulevard Brand Whitlock, 114/4
    Brussels 1200
    BELGIUM
  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    75%1
    50%1
    25%1

    Lobbyists (Full time equivalent)

    1.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 09 Jan 2018

    Name Start date End Date
    Ms Evelina KOZUBOVSKA 05 Mar 2024 28 Mar 2025
    Mr Rafal RAMOTOWSKI 22 Nov 2023 20 Nov 2024
    Ms Marilena VRANA 17 Nov 2023 15 Nov 2024
    Mr Maarten VAN BAELEN 17 Nov 2023 15 Nov 2024
    Mr Marek KORTUS 09 Nov 2023 08 Nov 2024
    Ms Halide TUNA 30 Sep 2023 27 Sep 2024
    Ms Tuna HALIDE 28 Sep 2023 30 Sep 2023
    Ms Alexa WETZEL 15 Sep 2023 13 Sep 2024
    Ms Evelina KOZUBOVSKA 17 Mar 2023 11 Mar 2024
    Mr Rafal RAMOTOWSKI 06 Dec 2022 22 Nov 2023
    Ms Marilena VRANA 02 Dec 2022 17 Nov 2023
    Mr Maarten VAN BAELEN 28 Sep 2022 28 Sep 2023
    Mr Karl Petrovsky 27 Sep 2022 30 Nov 2022
    Ms Athina GIANNOUTSOU 24 Jun 2022 25 Feb 2023
    Ms Alexa WETZEL 24 Jun 2022 23 Jun 2023
    Ms Evelina KOZUBOVSKA 25 Mar 2022 17 Mar 2023
    Mr Karl Petrovsky 07 Oct 2021 27 Sep 2022
    Ms Athina GIANNOUTSOU 09 Jul 2021 24 Jun 2022
    Ms Alexa WETZEL 09 Jul 2021 24 Jun 2022
    Mr Maarten VAN BAELEN 09 Jul 2021 09 Jul 2022
    Mr Karl Petrovsky 16 Jan 2020 16 Jan 2021
    Mr Karl Petrovsky 23 Jan 2019 16 Jan 2020
    Mr Karl Petrovsky 30 Jan 2018 23 Jan 2019
    Mr Bruno Santoni 23 Jan 2017 20 Jan 2018
    Mr Karl Petrovsky 23 Jan 2017 17 Jan 2018
    Mr Bruno Santoni 02 Feb 2016 19 Jan 2017
    Mr Karl Petrovsky 02 Feb 2016 19 Jan 2017
    Mr Bruno Santoni 13 Feb 2015 02 Feb 2016
    Mr Karl Petrovsky 13 Feb 2015 02 Feb 2016

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Karl Petrovsky (Senior Manager Health Policy Europe)

    Person with legal responsibility

    Mr Bruno Santoni (Executive Director, PPTA Europe)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Trade and business associations

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2016 - Dec 2016

    Lobbying costs for closed financial year

    350,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    http://pptaglobal.org/presentations-publications/presentations

    http://pptaglobal.org/presentations-publications/publications

    Other activities

    Healthcare - Pharmaceutical - Rare Diseases - Blood and blood component issues - Patient access to care with medicines/plasma protein therapeutics

  • Meetings

    Meetings

    4 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard